APA aipamena

Bek, S., Stritzke, F., Wintges, A., Nedelko, T., Böhmer, D. F., Fischer, J. C., . . . Heidegger, S. (2019). Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccines. Oncoimmunology.

Chicago Style aipamena

Bek, Sarah, Florian Stritzke, Alexander Wintges, Tatiana Nedelko, Daniel F.R Böhmer, Julius C. Fischer, Tobias Haas, Hendrik Poeck, and Simon Heidegger. "Targeting Intrinsic RIG-I Signaling Turns Melanoma Cells Into Type I Interferon-releasing Cellular Antitumor Vaccines." Oncoimmunology 2019.

MLA aipamena

Bek, Sarah, et al. "Targeting Intrinsic RIG-I Signaling Turns Melanoma Cells Into Type I Interferon-releasing Cellular Antitumor Vaccines." Oncoimmunology 2019.